Sana Biotechnology Stock Price Prediction

SANA Stock  USD 2.78  0.23  9.02%   
The RSI of Sana Biotechnology's share price is below 30 at this time. This usually implies that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Sana Biotechnology, making its price go up or down.

Oversold Vs Overbought

20

 
Oversold
 
Overbought
The successful prediction of Sana Biotechnology's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Sana Biotechnology, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Sana Biotechnology's stock price prediction:
EPS Estimate Next Quarter
(0.21)
EPS Estimate Current Year
(1.12)
EPS Estimate Next Year
(0.99)
Wall Street Target Price
10
EPS Estimate Current Quarter
(0.25)
Using Sana Biotechnology hype-based prediction, you can estimate the value of Sana Biotechnology from the perspective of Sana Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Sana Biotechnology to buy its stock at a price that has no basis in reality. In that case, they are not buying Sana because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Sana Biotechnology after-hype prediction price

    
  USD 2.78  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Sana Biotechnology Basic Forecasting Models to cross-verify your projections.
For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.
Intrinsic
Valuation
LowRealHigh
0.142.727.44
Details
Naive
Forecast
LowNextHigh
0.063.087.80
Details
7 Analysts
Consensus
LowTargetHigh
9.1010.0011.10
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.3-0.28-0.26
Details

Sana Biotechnology After-Hype Price Prediction Density Analysis

As far as predicting the price of Sana Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sana Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sana Biotechnology, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Sana Biotechnology Estimiated After-Hype Price Volatility

In the context of predicting Sana Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sana Biotechnology's historical news coverage. Sana Biotechnology's after-hype downside and upside margins for the prediction period are 0.14 and 7.50, respectively. We have considered Sana Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.78
2.78
After-hype Price
7.50
Upside
Sana Biotechnology is very risky at this time. Analysis and calculation of next after-hype price of Sana Biotechnology is based on 3 months time horizon.

Sana Biotechnology Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Sana Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sana Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sana Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.98 
4.72
  0.11 
  0.09 
10 Events / Month
15 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.78
2.78
0.00 
4,291  
Notes

Sana Biotechnology Hype Timeline

Sana Biotechnology is at this time traded for 2.78. The entity has historical hype elasticity of -0.11, and average elasticity to hype of competition of 0.09. Sana is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at -0.98%. %. The volatility of related hype on Sana Biotechnology is about 5154.02%, with the expected price after the next announcement by competition of 2.87. About 92.0% of the company shares are owned by institutional investors. The book value of Sana Biotechnology was at this time reported as 1.31. The company recorded a loss per share of 1.4. Sana Biotechnology had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be in about 10 days.
Check out Sana Biotechnology Basic Forecasting Models to cross-verify your projections.
For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.

Sana Biotechnology Related Hype Analysis

Having access to credible news sources related to Sana Biotechnology's direct competition is more important than ever and may enhance your ability to predict Sana Biotechnology's future price movements. Getting to know how Sana Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sana Biotechnology may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
OLMAOlema Pharmaceuticals(0.74)32 per month 0.00 (0.06) 6.17 (5.89) 19.19 
CGEMCullinan Oncology LLC(0.23)9 per month 0.00 (0.16) 5.88 (7.24) 17.85 
LIFEATyr Pharma 0.03 1 per month 2.62  0.07  6.45 (5.29) 28.98 
ZNTLZentalis Pharmaceuticals Llc 0.05 9 per month 5.06  0.05  11.41 (8.64) 33.76 
XFORX4 Pharmaceuticals 0.02 8 per month 0.00 (0.04) 8.82 (10.61) 62.35 
GRTXGalera Therapeutics(0.04)4 per month 0.00 (0.04) 7.31 (5.84) 18.16 
TERNTerns Pharmaceuticals 0.03 11 per month 0.00 (0.07) 6.02 (5.96) 34.09 
DAWNDay One Biopharmaceuticals 0.27 10 per month 2.77 (0.05) 3.84 (3.69) 11.44 
HOOKHookipa Pharma(0.19)7 per month 0.00 (0.30) 6.85 (6.67) 22.98 
RVMDRevolution Medicines 1.10 9 per month 2.00  0.14  4.81 (3.24) 10.95 
BPMCBlueprint Medicines Corp(0.37)10 per month 2.57 (0.02) 4.90 (3.62) 14.28 
KYMRKymera Therapeutics(0.63)11 per month 0.00 (0.05) 4.84 (4.74) 18.10 
GLUEMonte Rosa Therapeutics(0.74)8 per month 3.74  0.09  8.10 (8.18) 102.66 
NKTXNkarta Inc 0.26 6 per month 0.00 (0.18) 9.32 (7.83) 24.02 
LYELLyell Immunopharma 0.11 7 per month 0.00 (0.08) 13.39 (9.47) 36.92 
GBIOGeneration Bio Co(0.01)5 per month 0.00 (0.15) 9.35 (8.20) 25.48 
MRTXMirati Ther 0.00 0 per month 0.00 (0.18) 4.02 (4.07) 16.13 
AMLXAmylyx Pharmaceuticals 0.14 8 per month 4.11  0.27  10.06 (6.13) 33.56 
APLSApellis Pharmaceuticals 2.68 8 per month 0.00 (0.07) 4.48 (5.17) 15.97 

Sana Biotechnology Additional Predictive Modules

Most predictive techniques to examine Sana price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sana using various technical indicators. When you analyze Sana charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Sana Biotechnology Predictive Indicators

The successful prediction of Sana Biotechnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sana Biotechnology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sana Biotechnology based on analysis of Sana Biotechnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sana Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sana Biotechnology's related companies.
 2021 2022 2023 2024 (projected)
Net Debt To EBITDA0.40.270.120.11
Intangibles To Total Assets0.180.240.350.34

Story Coverage note for Sana Biotechnology

The number of cover stories for Sana Biotechnology depends on current market conditions and Sana Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sana Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sana Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Sana Biotechnology Short Properties

Sana Biotechnology's future price predictability will typically decrease when Sana Biotechnology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sana Biotechnology often depends not only on the future outlook of the potential Sana Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sana Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding194.5 M
Cash And Short Term Investments205.2 M

Complementary Tools for Sana Stock analysis

When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
CEOs Directory
Screen CEOs from public companies around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites